{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:45:51Z","timestamp":1790858751499,"version":"4.1.0"},"reference-count":178,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018231","name":"Aligning Science Across Parkinson&apos;s","doi-asserted-by":"publisher","award":["000525"],"award-info":[{"award-number":["000525"]}],"id":[{"id":"10.13039\/100018231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004089","name":"Krembil Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.tins.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:30:01Z","timestamp":1773293401000},"page":"328-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cell-autonomous and non-cell-autonomous drivers of dopamine neuron vulnerability in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7000-7046","authenticated-orcid":false,"given":"Alex","family":"Tchung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9838-1849","authenticated-orcid":false,"given":"Amandine","family":"Even","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4684-1377","authenticated-orcid":false,"given":"Louis-\u00c9ric","family":"Trudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2026.02.003_bb0005","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1021\/acsomega.4c09114","article-title":"Evolving landscape of Parkinson\u2019s disease research: challenges and perspectives","volume":"10","author":"Tenchov","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.tins.2026.02.003_bb0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fphar.2020.00435","article-title":"The noradrenergic system in Parkinson\u2019s disease","volume":"11","author":"Paredes-Rodriguez","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tins.2026.02.003_bb0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1474-4422(21)00377-X","article-title":"Cholinergic system changes in Parkinson\u2019s disease: emerging therapeutic approaches","volume":"21","author":"Bohnen","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2026.02.003_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177419","article-title":"Dysregulation of serotonergic neurotransmission in Parkinson disease: a key duet","volume":"995","author":"Khowdiary","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tins.2026.02.003_bb0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fneur.2018.00455","article-title":"On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease","volume":"9","author":"Gigu\u00e8re","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tins.2026.02.003_bb0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/brainsci14010100","article-title":"Exploring Parkinson\u2019s disease-associated depression: role of inflammation on the noradrenergic and serotonergic pathways","volume":"14","author":"Sampaio","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.tins.2026.02.003_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/ENEURO.0139-22.2022","article-title":"Axonal domain structure as a putative identifier of neuron-specific vulnerability to oxidative stress in cultured neurons","volume":"9","author":"Burke","year":"2022","journal-title":"eNeuro"},{"key":"10.1016\/j.tins.2026.02.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abp8701","article-title":"Ca2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons","volume":"8","author":"Zampese","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tins.2026.02.003_bb0045","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons","volume":"25","author":"Pacelli","year":"2015","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tins.2026.02.003_bb0050","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.3390\/cells9092045","article-title":"Calcium, bioenergetics, and Parkinson\u2019s disease","volume":"9","author":"Zampese","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.tins.2026.02.003_bb0055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41531-025-01055-3","article-title":"Parkinson\u2019s paradox: alpha-synuclein\u2019s selective strike on SNc dopamine neurons over VTA","volume":"11","author":"Phan","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease\u2014a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2026.02.003_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.681369","article-title":"Targeting of lysosomal pathway genes for Parkinson\u2019s disease modification: insights from cellular and animal models","volume":"12","author":"Abe","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tins.2026.02.003_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.691881","article-title":"The cross-links of endoplasmic reticulum stress, autophagy, and neurodegeneration in Parkinson\u2019s disease","volume":"13","author":"Ren","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2026.02.003_bb0075","doi-asserted-by":"crossref","first-page":"17296","DOI":"10.1073\/pnas.1922184117","article-title":"Dopaminergic neurodegeneration induced by Parkinson\u2019s disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity","volume":"117","author":"Nguyen","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tins.2026.02.003_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads3051","article-title":"Reduced DJ-1-F1Fo ATP synthase association correlates with midbrain dopaminergic neuron vulnerability in idiopathic Parkinson\u2019s disease","volume":"11","author":"Abulimiti","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tins.2026.02.003_bb0085","doi-asserted-by":"crossref","first-page":"9580","DOI":"10.1074\/jbc.RA117.000499","article-title":"Comparative analysis of Parkinson\u2019s disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons","volume":"293","author":"Gigu\u00e8re","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2026.02.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1042\/NS20220063","article-title":"Cytokine activity in Parkinson\u2019s disease","volume":"7","author":"Dzamko","year":"2023","journal-title":"Neuronal Signal."},{"key":"10.1016\/j.tins.2026.02.003_bb0095","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0100","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1093\/brain\/awaa269","article-title":"CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson\u2019s disease","volume":"143","author":"Galiano-Landeira","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.tins.2026.02.003_bb0105","doi-asserted-by":"crossref","first-page":"9832","DOI":"10.1038\/s41598-021-89210-7","article-title":"Methylmercury induces neuronal cell death by inducing TNF-\u03b1 expression through the ASK1\/p38 signaling pathway in microglia","volume":"11","author":"Toyama","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2026.02.003_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/JPD-202279","article-title":"Infection and risk of Parkinson\u2019s disease","volume":"11","author":"Smeyne","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41531-024-00681-7","article-title":"Diet and the gut microbiome in patients with Parkinson\u2019s disease","volume":"10","author":"Kwon","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0120","article-title":"Meta-analysis of brain iron levels of Parkinson\u2019s disease patients determined by postmortem and MRI measurements","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2026.02.003_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.118255","article-title":"Measuring the iron content of dopaminergic neurons in substantia nigra with MRI relaxometry","volume":"239","author":"Brammerloh","year":"2021","journal-title":"Neuroimage"},{"key":"10.1016\/j.tins.2026.02.003_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41531-025-01250-2","article-title":"Multi-omic insight into the molecular mechanism of cuproptosis-related genes in the pathogenesis of Parkinson\u2019s disease","volume":"12","author":"Zhang","year":"2026","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0135","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1039\/C7MT00244K","article-title":"Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson\u2019s disease brain","volume":"9","author":"Genoud","year":"2017","journal-title":"Metallomics"},{"key":"10.1016\/j.tins.2026.02.003_bb0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s40478-020-01083-5","article-title":"Neuroinflammation and protein pathology in Parkinson\u2019s disease dementia","volume":"8","author":"Kouli","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tins.2026.02.003_bb0145","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1073\/pnas.1909110117","article-title":"NK cells clear \u03b1-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of \u03b1-synucleinopathy","volume":"117","author":"Earls","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tins.2026.02.003_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.70016","article-title":"The intricate interplay: microbial metabolites and the gut-liver-brain axis in Parkinson\u2019s disease","volume":"103","author":"Kollaparampil Kishanchand","year":"2025","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.tins.2026.02.003_bb0155","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/cdd.2014.216","article-title":"Old, new and emerging functions of caspases","volume":"22","author":"Shalini","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tins.2026.02.003_bb0160","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s12276-023-01069-y","article-title":"Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.tins.2026.02.003_bb0165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/ars.2020.8229","article-title":"Cell death-osis of dopaminergic neurons and the role of iron in Parkinson\u2019s disease","volume":"35","author":"Lima","year":"2021","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tins.2026.02.003_bb0170","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbi.2024.03.038","article-title":"Pyroptosis-mediator GSDMD promotes Parkinson\u2019s disease pathology via microglial activation and dopaminergic neuronal death","volume":"119","author":"Zhang","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tins.2026.02.003_bb0175","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41531-018-0061-5","article-title":"NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson\u2019s disease","volume":"4","author":"von Herrmann","year":"2018","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41531-020-00147-6","article-title":"Plasma-borne indicators of inflammasome activity in Parkinson\u2019s disease patients","volume":"7","author":"Anderson","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0185","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.tins.2026.02.003_bb0190","article-title":"The roles of AIM2 in neurodegenerative diseases: insights and therapeutic implications","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tins.2026.02.003_bb0195","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s44321-024-00046-w","article-title":"Cytosolic DNA sensors in neurodegenerative diseases: from physiological defenders to pathological culprits","volume":"16","author":"Xie","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.tins.2026.02.003_bb0200","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: an ordered cellular explosion","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tins.2026.02.003_bb0205","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.cell.2018.03.032","article-title":"The structure of the necrosome RIPK1-RIPK3 core, a human hetero-amyloid signaling complex","volume":"173","author":"Mompe\u00e1n","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.tins.2026.02.003_bb0210","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1073\/pnas.1917112117","article-title":"CK1\u03b1, CK1\u03b4, and CK1\u03b5 are necrosome components which phosphorylate serine 227 of human RIPK3 to activate necroptosis","volume":"117","author":"Hanna-Addams","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tins.2026.02.003_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147310","article-title":"RIPK1 inhibitor ameliorates the MPP+\/MPTP-induced Parkinson\u2019s disease through the ASK1\/JNK signalling pathway","volume":"1757","author":"Liu","year":"2021","journal-title":"Brain Res."},{"key":"10.1016\/j.tins.2026.02.003_bb0220","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41418-019-0408-4","article-title":"The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease","volume":"27","author":"O\u00f1ate","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tins.2026.02.003_bb0225","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tins.2026.02.003_bb0230","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1471-4159.1990.tb08814.x","article-title":"Decreased ferritin levels in brain in Parkinson\u2019s disease","volume":"55","author":"Dexter","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2026.02.003_bb0235","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173110","article-title":"Midbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons","volume":"133","author":"Sun","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tins.2026.02.003_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102214","article-title":"The mechanism of cuproptosis in Parkinson\u2019s disease","volume":"95","author":"Huang","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.tins.2026.02.003_bb0245","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3390\/brainsci13071015","article-title":"Identification of cuproptosis clusters and integrative analyses in Parkinson\u2019s disease","volume":"13","author":"Zhang","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.tins.2026.02.003_bb0250","article-title":"Cuproptosis-related genes associated with mitochondrial dysfunction in Parkinson\u2019s disease","volume":"20","author":"Liu","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2026.02.003_bb0255","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41531-025-00928-x","article-title":"Linking Parkinson\u2019s disease and melanoma: the impact of copper-driven cuproptosis and related mechanisms","volume":"11","author":"Wang","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0260","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/cdd.2011.96","article-title":"Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012","volume":"19","author":"Galluzzi","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tins.2026.02.003_bb0265","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","article-title":"Molecular mechanisms of cell death in neurological diseases","volume":"28","author":"Moujalled","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tins.2026.02.003_bb0270","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fcimb.2019.00406","article-title":"ZBP1 and TAK1: master regulators of NLRP3 inflammasome\/pyroptosis, apoptosis, and necroptosis (PAN-optosis)","volume":"9","author":"Malireddi","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.tins.2026.02.003_bb0275","article-title":"Mitochondrial-dependent and independent functions of PINK1","volume":"10","author":"Chen","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tins.2026.02.003_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108253","article-title":"Transmembrane Parkinson\u2019s disease mutation of PINK1 leads to altered mitochondrial anchoring","volume":"301","author":"Brassard","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2026.02.003_bb0285","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","article-title":"Parkinson\u2019s disease-related proteins PINK1 and Parkin repress mitochondrial antigen presentation","volume":"166","author":"Matheoud","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tins.2026.02.003_bb0290","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/embj.201385902","article-title":"Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control","volume":"33","author":"McLelland","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.tins.2026.02.003_bb0295","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/mds.29025","article-title":"Parkin deficiency impairs mitochondrial DNA dynamics and propagates inflammation","volume":"37","author":"Wasner","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tins.2026.02.003_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113707","article-title":"Progressive parkinsonism due to mitochondrial impairment: lessons from the MitoPark mouse model","volume":"341","author":"Beckstead","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tins.2026.02.003_bb0305","doi-asserted-by":"crossref","first-page":"17649","DOI":"10.1523\/JNEUROSCI.4871-11.2011","article-title":"Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson\u2019s disease","volume":"31","author":"Pickrell","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2026.02.003_bb0310","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","article-title":"Disruption of mitochondrial complex I induces progressive parkinsonism","volume":"599","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tins.2026.02.003_bb0315","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/brainsci13121717","article-title":"Differential effects of paraquat, rotenone, and MPTP on cellular bioenergetics of undifferentiated and differentiated human neuroblastoma cells","volume":"13","author":"Elmorsy","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.tins.2026.02.003_bb0320","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41531-023-00561-6","article-title":"Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy","volume":"9","author":"Van Laar","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0325","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.cdd.4400629","article-title":"Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis","volume":"7","author":"Chen","year":"2000","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tins.2026.02.003_bb0330","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11064-021-03262-9","article-title":"Benefits of iron chelators in the treatment of Parkinson\u2019s disease","volume":"46","author":"Zeng","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tins.2026.02.003_bb0335","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.1038\/onc.2015.35","article-title":"Reactive oxygen species regulate Smac mimetic\/TNF\u03b1-induced necroptotic signaling and cell death","volume":"34","author":"Schenk","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.tins.2026.02.003_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.630771","article-title":"The role of mitochondria in pyroptosis","volume":"8","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tins.2026.02.003_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.826193","article-title":"Evidence that substantia nigra pars compacta dopaminergic neurons are selectively vulnerable to oxidative stress because they are highly metabolically active","volume":"16","author":"Ni","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tins.2026.02.003_bb0350","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1021\/acs.chemrestox.5c00058","article-title":"Facile biological oxidation of dopamine to 6-hydroxydopamine P-quinone in a sequential two-step process: implications for Parkinson\u2019s disease","volume":"38","author":"Jiang","year":"2025","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tins.2026.02.003_bb0355","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.tins.2026.02.003_bb0360","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.freeradbiomed.2013.06.030","article-title":"Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4","volume":"65","author":"Hauser","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tins.2026.02.003_bb0365","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","article-title":"Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria","volume":"73","author":"Berman","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2026.02.003_bb0370","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.freeradbiomed.2004.02.013","article-title":"Reactive oxygen species induce different cell death mechanisms in cultured neurons","volume":"36","author":"Valencia","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tins.2026.02.003_bb0375","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.tins.2026.02.003_bb0380","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/cells13040296","article-title":"Pathogenesis of DJ-1\/PARK7-mediated Parkinson\u2019s disease","volume":"13","author":"Skou","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.tins.2026.02.003_bb0385","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40478-022-01488-4","article-title":"Parkin coregulates glutathione metabolism in adult mammalian brain","volume":"11","author":"El Kodsi","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tins.2026.02.003_bb0390","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00401-021-02285-4","article-title":"Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites","volume":"141","author":"Tokarew","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2026.02.003_bb0395","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41593-019-0556-3","article-title":"Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain","volume":"23","author":"Graves","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2026.02.003_bb0400","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3389\/fnins.2018.00859","article-title":"Kinetic modeling of pH-dependent oxidation of dopamine by iron and its relevance to Parkinson\u2019s disease","volume":"12","author":"Sun","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tins.2026.02.003_bb0405","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1471-4159.1991.tb06432.x","article-title":"Intranigral iron injection induces behavioral and biochemical \u2018parkinsonism\u2019 in rats","volume":"57","author":"Ben-Shachar","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2026.02.003_bb0410","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1073\/pnas.1519473113","article-title":"Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice","volume":"113","author":"Matak","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tins.2026.02.003_bb0415","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuroscience.2017.05.050","article-title":"Alterations in neuronal control of body weight and anxiety behavior by glutathione peroxidase 4 deficiency","volume":"357","author":"Schriever","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2026.02.003_bb0420","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","article-title":"Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2026.02.003_bb0425","article-title":"Identification of cuproptosis-realated key genes and pathways in Parkinson\u2019s disease via bioinformatics analysis","volume":"19","author":"Song","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2026.02.003_bb0430","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41419-021-04138-0","article-title":"Alpha-synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion","volume":"12","author":"Tang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0435","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1111\/febs.15326","article-title":"Intracellular cathepsin C levels determine sensitivity of cells to leucyl-leucine methyl ester-triggered apoptosis","volume":"287","author":"Kav\u010di\u010d","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.tins.2026.02.003_bb0440","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40478-020-0894-0","article-title":"Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by \u03b1-synuclein","volume":"8","author":"McKinnon","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tins.2026.02.003_bb0445","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3390\/antiox11122466","article-title":"Neuronal oxidative stress promotes \u03b1-synuclein aggregation in vivo","volume":"11","author":"Won","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.tins.2026.02.003_bb0450","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the \u03b1-synuclein protofibril by a dopamine-\u03b1-synuclein adduct","volume":"294","author":"Conway","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tins.2026.02.003_bb0455","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/nn.4641","article-title":"Dopamine induces soluble \u03b1-synuclein oligomers and nigrostriatal degeneration","volume":"20","author":"Mor","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2026.02.003_bb0460","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41419-021-03441-0","article-title":"Expanding the role of proteasome homeostasis in Parkinson\u2019s disease: beyond protein breakdown","volume":"12","author":"Bi","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0465","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/hmg\/ddx179","article-title":"Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila","volume":"26","author":"Inoshita","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2026.02.003_bb0470","doi-asserted-by":"crossref","first-page":"8484","DOI":"10.1038\/s41467-025-63444-9","article-title":"Synaptic vesicle endocytosis deficits underlie cognitive dysfunction in mouse models of GBA-linked Parkinson\u2019s disease and dementia with Lewy bodies","volume":"16","author":"Vidyadhara","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2026.02.003_bb0475","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41421-021-00334-6","article-title":"Cryo-EM structures and transport mechanism of human P5B type ATPase ATP13A2","volume":"7","author":"Chen","year":"2021","journal-title":"Cell Discov."},{"key":"10.1016\/j.tins.2026.02.003_bb0505","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3390\/ijms22052689","article-title":"ATP13A2 regulates cellular \u03b1-synuclein multimerization, membrane association, and externalization","volume":"22","author":"Si","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tins.2026.02.003_bb0510","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41531-024-00748-5","article-title":"Adult-onset deletion of ATP13A2 in mice induces progressive nigrostriatal pathway dopaminergic degeneration and lysosomal abnormalities","volume":"10","author":"Erb","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0515","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41531-024-00757-4","article-title":"Nigral ATP13A2 depletion induces Parkinson\u2019s disease-related neurodegeneration in a pilot study in non-human primates","volume":"10","author":"Sikora","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0520","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-025-02908-0","article-title":"Loss of the lysosomal lipid flippase ATP10B leads to progressive dopaminergic neurodegeneration and parkinsonian motor deficits","volume":"150","author":"Sanchiz-Calvo","year":"2025","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2026.02.003_bb0525","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tins.2026.02.003_bb0530","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2017.06.020","article-title":"Local cues establish and maintain region-specific phenotypes of basal ganglia microglia","volume":"95","author":"De Biase","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2026.02.003_bb0535","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2026.02.003_bb0540","first-page":"90","article-title":"Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson\u2019s disease patients","volume":"2","author":"Doorn","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tins.2026.02.003_bb0545","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tins.2026.02.003_bb0550","doi-asserted-by":"crossref","first-page":"E5164","DOI":"10.1073\/pnas.1718946115","article-title":"Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson\u2019s disease","volume":"115","author":"Kim","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tins.2026.02.003_bb0555","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s42003-025-08544-4","article-title":"LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson\u2019s disease model","volume":"8","author":"Blasco-Agell","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.tins.2026.02.003_bb0560","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1111\/febs.12401","article-title":"Rotenone induces neuronal death by microglial phagocytosis of neurons","volume":"280","author":"Emmrich","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.tins.2026.02.003_bb0565","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13041-023-01059-1","article-title":"\u03b1-Synuclein propagation leads to synaptic abnormalities in the cortex through microglial synapse phagocytosis","volume":"16","author":"P\u00e9rez-Acu\u00f1a","year":"2023","journal-title":"Mol. Brain"},{"key":"10.1016\/j.tins.2026.02.003_bb0570","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/glia.23199","article-title":"Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus","volume":"65","author":"Aono","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.tins.2026.02.003_bb0575","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","article-title":"MHCII is required for \u03b1-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration","volume":"33","author":"Harms","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2026.02.003_bb0580","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.726421","article-title":"Microglia and perivascular macrophages act as antigen presenting cells to promote CD8 T cell infiltration of the brain","volume":"12","author":"Goddery","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tins.2026.02.003_bb0585","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebri\u00e1n","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2026.02.003_bb0590","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tins.2026.02.003_bb0595","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-019-1405-y","article-title":"Intestinal infection triggers Parkinson\u2019s disease-like symptoms in Pink1\u2212\/\u2212 mice","volume":"571","author":"Matheoud","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tins.2026.02.003_bb0600","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49294-9","article-title":"Human iPSC-derived microglia carrying the LRRK2-G2019S mutation show a Parkinson\u2019s disease related transcriptional profile and function","volume":"13","author":"Ohtonen","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2026.02.003_bb0605","article-title":"PINK1 is a target of T cell responses in Parkinson\u2019s disease","volume":"135","author":"Williams","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tins.2026.02.003_bb0610","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1038\/s41467-025-62478-3","article-title":"The spatial landscape of glial pathology and T cell response in Parkinson\u2019s disease substantia nigra","volume":"16","author":"Ma","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2026.02.003_bb0615","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41401-023-01147-x","article-title":"Gut microbiota-induced CXCL1 elevation triggers early neuroinflammation in the substantia nigra of Parkinsonian mice","volume":"45","author":"Ma","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.tins.2026.02.003_bb0620","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","article-title":"The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis","volume":"40","author":"Booth","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tins.2026.02.003_bb0625","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1186\/s12964-024-01928-9","article-title":"Dysregulation of protein degradation and alteration of secretome in \u03b1-synuclein-exposed astrocytes: implications for dopaminergic neuronal dysfunction","volume":"22","author":"Raj","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.tins.2026.02.003_bb0630","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00401-022-02437-0","article-title":"Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson\u2019s disease","volume":"144","author":"Iovino","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2026.02.003_bb0635","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70110","article-title":"Multi-omic analysis of glutamate excitotoxicity in primary neuronal cultures","volume":"169","author":"Nguyen","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2026.02.003_bb0640","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41419-021-04049-0","article-title":"Fibrillar \u03b1-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-\u03baB","volume":"12","author":"Chou","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0645","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41531-023-00626-6","article-title":"Immunological shifts during early-stage Parkinson\u2019s disease identified with DNA methylation data on longitudinally collected blood samples","volume":"10","author":"Pike","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0650","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/brain\/awaf066","article-title":"Mapping the peripheral immune landscape of Parkinson\u2019s disease patients with single-cell sequencing","volume":"148","author":"Moquin-Beaudry","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.tins.2026.02.003_bb0655","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41531-023-00457-5","article-title":"Peripheral inflammatory immune response differs among sporadic and familial Parkinson\u2019s disease","volume":"9","author":"Mu\u00f1oz-Delgado","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0660","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41421-021-00280-3","article-title":"Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson\u2019s disease","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Discov."},{"key":"10.1016\/j.tins.2026.02.003_bb0665","article-title":"Association analysis of dopaminergic degeneration and the neutrophil-to-lymphocyte ratio in Parkinson\u2019s disease","volume":"16","author":"Zhang","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2026.02.003_bb0670","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41531-025-01001-3","article-title":"T cell responses towards PINK1 and \u03b1-synuclein are elevated in prodromal Parkinson\u2019s disease","volume":"11","author":"Johansson","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0675","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/1521-4141(200012)30:12<3623::AID-IMMU3623>3.0.CO;2-F","article-title":"MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas\/FasL, but not the perforin pathway","volume":"30","author":"Medana","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.tins.2026.02.003_bb0680","article-title":"Adoptive transfer of mitochondrial antigen-specific CD8+ T-cells in mice causes parkinsonism and compromises the dopamine system","author":"Elemeery","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.tins.2026.02.003_bb0685","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awab103","article-title":"CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease","volume":"144","author":"Williams","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.tins.2026.02.003_bb0690","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1007\/s12035-016-0249-9","article-title":"Th17 cells induce dopaminergic neuronal death via LFA-1\/ICAM-1 interaction in a mouse model of Parkinson\u2019s disease","volume":"54","author":"Liu","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tins.2026.02.003_bb0695","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/s12276-020-00505-7","article-title":"The role of natural killer cells in Parkinson\u2019s disease","volume":"52","author":"Earls","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.tins.2026.02.003_bb0700","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41531-024-00652-y","article-title":"Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson\u2019s disease patients","volume":"10","author":"Weber","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0705","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.992505","article-title":"Single-cell RNA sequencing of CSF reveals neuroprotective RAC1+ NK cells in Parkinson\u2019s disease","volume":"13","author":"Guan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tins.2026.02.003_bb0710","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12974-020-1730-y","article-title":"Neutrophil-selective deletion of Cxcr2 protects against CNS neurodegeneration in a mouse model of multiple sclerosis","volume":"17","author":"Khaw","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tins.2026.02.003_bb0715","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s12276-022-00805-0","article-title":"ROS-activated CXCR2+ neutrophils recruited by CXCL1 delay denervated skeletal muscle atrophy and undergo P53-mediated apoptosis","volume":"54","author":"Xiang","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.tins.2026.02.003_bb0720","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41531-022-00295-x","article-title":"Gastrointestinal involvement in Parkinson\u2019s disease: pathophysiology, diagnosis, and management","volume":"8","author":"Warnecke","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0725","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41531-025-00945-w","article-title":"PINK1 deficiency rewires early immune responses in a mouse model of Parkinson\u2019s disease triggered by intestinal infection","volume":"11","author":"Recinto","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0730","doi-asserted-by":"crossref","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","article-title":"Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease","volume":"98","author":"Chen","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2026.02.003_bb0735","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12264-023-01123-9","article-title":"Relationship between short-chain fatty acids and Parkinson\u2019s disease: a review from pathology to clinic","volume":"40","author":"Duan","year":"2024","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.tins.2026.02.003_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111376","article-title":"Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson\u2019s disease","volume":"150","author":"Hou","year":"2021","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.tins.2026.02.003_bb0745","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40168-020-00988-6","article-title":"Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson\u2019s disease","volume":"9","author":"Hou","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.tins.2026.02.003_bb0750","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18363-w","article-title":"Brief exposure of neuronal cells to levels of SCFAs observed in human systemic circulation impair lipid metabolism resulting in apoptosis","volume":"12","author":"Fillier","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2026.02.003_bb0755","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tins.2026.02.003_bb0760","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1007\/s12035-025-04726-7","article-title":"Short-chain fatty acid aggregates alpha-synuclein accumulation and neuroinflammation via GPR43-NLRP3 signaling pathway in a model Parkinson\u2019s disease","volume":"62","author":"Qu","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tins.2026.02.003_bb0765","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.3233\/JPD-223277","article-title":"Blood and cerebrospinal fluid biomarkers of inflammation in Parkinson\u2019s disease","volume":"12","author":"Zimmermann","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0770","first-page":"113","article-title":"Biochemistry of postmortem brains in Parkinson\u2019s disease: historical overview and future prospects","author":"Nagatsu","year":"2007","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.tins.2026.02.003_bb0775","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.bbi.2024.10.025","article-title":"Bidirectional interaction between IL and 17A\/IL-17RA pathway dysregulation and \u03b1-synuclein in the pathogenesis of Parkinson\u2019s disease","volume":"123","author":"Yan","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tins.2026.02.003_bb0780","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1\u03b2, interleukin-6, epidermal growth factor and transforming growth factor-\u03b1 are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2026.02.003_bb0785","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/bjsports-2013-092438","article-title":"Substance P reduces TNF-\u03b1-induced apoptosis in human tenocytes through NK-1 receptor stimulation","volume":"48","author":"Backman","year":"2014","journal-title":"Br. J. Sports Med."},{"key":"10.1016\/j.tins.2026.02.003_bb0790","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/exnr.2001.7688","article-title":"Tumor necrosis factor \u03b1 is toxic to embryonic mesencephalic dopamine neurons","volume":"169","author":"McGuire","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tins.2026.02.003_bb0795","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1471-4159.2010.06763.x","article-title":"Excitotoxicity of TNF\u03b1 derived from KA activated microglia on hippocampal neurons in vitro and in vivo","volume":"114","author":"Zhu","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2026.02.003_bb0800","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","article-title":"Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson\u2019s disease","volume":"23","author":"Sommer","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tins.2026.02.003_bb0805","first-page":"201","article-title":"Is cellular senescence of dopaminergic neurons the cause of local inflammation in the midbrain observed in Parkinson\u2019s disease?","volume":"2","author":"Riessland","year":"2020","journal-title":"J. Cell. Immunol."},{"key":"10.1016\/j.tins.2026.02.003_bb0810","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0006-8993(03)03172-X","article-title":"Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice","volume":"985","author":"Cardenas","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.tins.2026.02.003_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110358","article-title":"Interleukin-6 triggers toxic neuronal iron sequestration in response to pathological \u03b1-synuclein","volume":"38","author":"Sterling","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tins.2026.02.003_bb0820","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2006.06.013","article-title":"Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1\u03b2 in the substantia nigra","volume":"24","author":"Ferrari","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0825","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/ijnp\/pyaa060","article-title":"Baicalein attenuates neuroinflammation by inhibiting NLRP3\/caspase-1\/GSDMD pathway in MPTP-induced mice model of Parkinson\u2019s disease","volume":"23","author":"Rui","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.tins.2026.02.003_bb0830","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1073\/pnas.95.10.5789","article-title":"Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity","volume":"95","author":"Offen","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tins.2026.02.003_bb0835","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/hmg\/ddm080","article-title":"Apoptotic mechanisms in mutant LRRK2-mediated cell death","volume":"16","author":"Iaccarino","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2026.02.003_bb0840","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1073\/pnas.191107398","article-title":"An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson\u2019s disease","volume":"98","author":"Mochizuki","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tins.2026.02.003_bb0845","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.lfs.2015.11.019","article-title":"Pre-administration of BAX-inhibiting peptides decrease the loss of the nigral dopaminergic neurons in rats","volume":"144","author":"Ma","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.tins.2026.02.003_bb0850","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.neuro.2011.12.007","article-title":"Uncoupling of ATP-depletion and cell death in human dopaminergic neurons","volume":"33","author":"P\u00f6ltl","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.tins.2026.02.003_bb0855","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.1523\/JNEUROSCI.20-24-09126.2000","article-title":"Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"20","author":"Eberhardt","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2026.02.003_bb0860","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1523\/JNEUROSCI.21-07-02247.2001","article-title":"Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease, but pathway inhibition results in neuronal necrosis","volume":"21","author":"Hartmann","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2026.02.003_bb0865","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41419-024-07014-9","article-title":"Dopaminergic neurons lacking caspase-3 avoid apoptosis but undergo necrosis after MPTP treatment inducing a galectin-3-dependent selective microglial phagocytic response","volume":"15","author":"Garc\u00eda-Revilla","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tins.2026.02.003_bb0870","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1016\/j.febslet.2006.05.066","article-title":"Differential regulation of the intrinsic pathway of apoptosis in brain and liver during ageing","volume":"580","author":"Stoka","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tins.2026.02.003_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105896","article-title":"Neuroprotective and anti-inflammatory effects of the RIPK3 inhibitor GSK872 in an MPTP-induced mouse model of Parkinson\u2019s disease","volume":"181","author":"Park","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.tins.2026.02.003_bb0880","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4062\/biomolther.2025.049","article-title":"MLKL inhibitor reduces oxidative stress, inflammation, and dopaminergic neuronal cell death in MPTP-induced Parkinson\u2019s disease mouse model","volume":"33","author":"Kim","year":"2025","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.tins.2026.02.003_bb0885","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1038\/s41598-023-35975-y","article-title":"Necrosulfonamide exerts neuroprotective effect by inhibiting necroptosis, neuroinflammation, and \u03b1-synuclein oligomerization in a subacute MPTP mouse model of Parkinson\u2019s disease","volume":"13","author":"Leem","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2026.02.003_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114809","article-title":"Reduction of D2 receptors on microglia leads to ZBP1-mediated PANoptosis of mPFC in Parkinson\u2019s disease depression mice","volume":"158","author":"Zhao","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tins.2026.02.003_bb0895","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s00204-020-02826-y","article-title":"Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants","volume":"94","author":"Gutbier","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tins.2026.02.003_bb0900","doi-asserted-by":"crossref","first-page":"10401","DOI":"10.2147\/IJN.S479670","article-title":"Exenatide-modified deferoxamine-based nanoparticles ameliorates neurological deficits in Parkinson\u2019s disease mice","volume":"19","author":"Huang","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.tins.2026.02.003_bb0905","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313042","article-title":"Targeting ferroptosis in Parkinson\u2019s disease: mechanisms and emerging therapeutic strategies","volume":"25","author":"Zhou","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tins.2026.02.003_bb0910","article-title":"Aging, Parkinson\u2019s disease, and models: what are the challenges?","volume":"1","author":"Rocha","year":"2023","journal-title":"Aging Biol."},{"key":"10.1016\/j.tins.2026.02.003_bb0915","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41531-025-01239-x","article-title":"Unraveling the intersection of aging and Parkinson\u2019s disease: a collaborative roadmap for advancing research models","volume":"12","author":"Schmidt","year":"2026","journal-title":"NPJ Parkinsons Dis."}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223626000275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223626000275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:26:58Z","timestamp":1784528818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223626000275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":178,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0166223626000275"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2026.02.003","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-autonomous and non-cell-autonomous drivers of dopamine neuron vulnerability in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}